Prolonged bleeding time in patients with lupus anticoagulant

Area of Science:

• Hematology
• Immunology
• Rheumatology

Background:

• Lupus anticoagulant (LA) is an autoimmune condition associated with an increased risk of thrombosis.
• Platelet function is crucial for hemostasis, and defects in platelet adhesion can lead to bleeding or clotting disorders.

Purpose of the Study:

• To investigate platelet adhesion to collagen under flow conditions in patients with lupus anticoagulant.
• To determine the role of plasma factors and antiphospholipid antibodies in platelet adhesion defects in LA patients.

Main Methods:

• Studied platelet adhesion to collagen under flow in 18 LA patients and controls.
• Assessed the impact of patient plasma, IgG, and purified anticardiolipin antibodies on platelet adhesion.

Main Results:

• Significant reduction in platelet adhesion observed in LA patients, particularly those with prolonged bleeding times.
• Platelet adhesion defects were normalized by mixing patient platelets with normal plasma, indicating a plasma factor.
• Purified immunoglobulins and anticardiolipin antibodies demonstrated a causative role in the observed platelet dysfunction.

Conclusions:

• Patients with lupus anticoagulant exhibit impaired platelet adhesion to collagen.
• Antiphospholipid antibodies and plasma factors contribute to platelet adhesion defects in LA, potentially influencing bleeding risk.